Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon

American Journal of Gastroenterology

Volumn 94, Issue 5, 1999, Pages 1366-1372

  Oliveri, Filippo ^a   Santantonio, Teresa ^a  

^a ROCHE MILANO RICERCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; ALPHAN1 INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RELAPSE; REMISSION; SCORING SYSTEM;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; INTERFERONS; LIVER; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 0033134866     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00144-6     Document Type: Article

References (26)

1. Bonino F, Hoyer B, Nelson J, et al. Hepatitis B virus DNA in thé sera of HBsAg carriers - A marker of active hepatitis B virus replication in the liver. Hepatology 1981; 1:386-91.
2. Hadziyannis SJ, Lieberman HM, Karvountzis GG, et al. Analysis of liver, nuclear HBcAg, viral replication and hepatitis B virus DNA in liver and serum of HBeAg versus anti-HBe positive carriers of hepatitis B virus. Hepatology 1983;3:656-62.
3. Lok ASF, Hadziyannis SJ, Weller IVD. Contribution of low levels of HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. Gut 1984;25:1283-7.
4. Tur-Kaspa RJ, Keshet E, Eliakim M, et al. Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers. Med Virol 1984;14:17-26.
5. Shafritz DA. Presence of hepatitis B virus deoxyribonucleic acid in human tissues under unexpected circumstances. Gastroenterology 1985;89:687-90.
6. Brunette MR, Oliven F, Rocca G, et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989;10:198-202.
7. Bonino F, Rosina F, Rizzetto M, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986;90:1268-73.
8. Brunetto MR, Stemler M, Schodel F, et al. Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989;21:151-4.
9. Carman WF, Hadziyannis SJ, McGarvey MJ, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;1:588-90.
10. Tong SP, Li J, Vitvitski L, et al. Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region. Virology 1990; 176:596-603.
11. Okamoto H, Yotsumoto S, Akahane Y, et al. Hepatitis B viruses with precore region defects pravail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990;64:1298-1303.
12. Brunetto MR, Giarin E, Oliveri F, et al. Wild-type and "e" antigen minus hepatitis viruses and course of chronic hepatitis. Proc Nat Acad Sei USA 1991;88:4186-90.
13. Raimondo G, Stemler M, Schneider R, et al. Latency arid reactivation of a pro-core mutant hepatitis B virus in a chronically infected patient. J Hepatol 1990;11:374-80.
14. Santantonio T, Jung MC, Schneider R, et al. Selection for a pre-C stop codon mutation in hepatitis B virus variant with a pre-C initiation codon mutation during IFN treatment. J Hepatol 1991:13:368-71.
15. Raimondo G, Rodinö G, Smedile V, et al. Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis. J Hepatol 1990:10:271-3.
16. Brunetto MR, Torrani Cerenzia M, Oliveri F, et al. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 1993;19:431-6.
17. Colloredo Mels G, Bellati G, Leandro G, et al. Fluctuations of viremia aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver 1994:14:175-81.
18. Hadziyannis S, Bramou T, Makris A, et al. Interferon alpha-2b treatment of HBeAg negative/serum HBV-DNA positive chronic hepatitis type B. J Hepatol 1990;11(suppl 1):S133-6.
19. Fattovich G, Farci P, Rugge M, et al. A randomized controlled trial of lymphoblastoid IFN-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology 1991;15:584-9.
20. Pastore G, Santantonio T, Milella N, et al. Anti-HBe positive chronic hepatitis B with HBV-DNA in the serum: Response to a six month course of lymphoblastoid IFN. J Hepatol 1992; 14:221-5.
21. Brunetto MR, Oliveri F, Colombatto P, et al. Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha J Hepatol 1995;22(suppl l):42-4.
22. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;4:431-5.
23. Roitt IM. Essential immunology, 4th ed. London: Blackwell Scientific Publications, 1992.
24. Dianzani F, Zucca M, Scupham A, et al. Immune and virus induced IFNs may activate cells by different depressional mechanisms. Nature 1980;282:400.
25. Pestka S, Langer JA, Zoon KC, et al. Interferons and their actions. Annu Rev Biochem 1987;56:727.
26. Samuel CE. Mechanisms of the antiviral action of interferons. Proc Nucl Acid.Res 1988;35:27.